diaziquone has been researched along with Local Neoplasm Recurrence in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (73.68) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Damaschke, N; Guenther, C; Huang, W; Jarrard, D; McCormick, J; Truong, M; Wagner, J; Yang, B | 1 |
| Bedikian, AY; Benjamin, RS; Burgess, MA; Feun, LG; Fields, WS; Leavens, ME; Obbens, EA; Savaraj, N; Stewart, DJ; Yung, WK | 1 |
| Anderson, B; Blessing, JA; Look, K; Slayton, RE | 1 |
| Burger, P; Castleberry, RP; Kamen, B; Krischer, JP; Norris, D; Ragab, AH; Starling, K; Steuber, CP; Toledano, S | 1 |
| Ettinger, LJ; Hammond, GD; Krailo, MD; Krivit, WA; Ru, N; Ruccione, KS | 1 |
| Amrein, PC; Davis, RB; Mayer, RJ; Schiffer, CA | 1 |
| Coleman, RE; Djang, WT; Falletta, JM; Friedman, HS; Halperin, EC; Kurtzberg, J; Longee, DC; Oakes, WJ; Schold, SC | 1 |
| Bruner, JM; Feun, LG; Harris, MI; Yung, WK | 1 |
| Al Sarraf, M; Austin, D; Decker, DA; Kresge, C; Wilner, HI | 1 |
| Bender, JF; Chaffee, B; Ensminger, WD; Gebarski, S; Greenberg, HS; Grillo-Lopez, AJ; Layton, PB; Meyer, M | 1 |
| Albright, RE; Bullard, DE; Burger, PC; Cairncross, JG; DeLong, ER; Friedman, HS; Khandekar, JD; Mahaley, MS; Schold, SC; Vick, NA | 1 |
| Blessing, JA; DiSaia, PJ; Phillips, G; Slayton, RE | 1 |
| Chamberlain, MC; Levin, VA; Prados, MD; Silver, P | 1 |
| Al-Sarraf, M; Ensley, J; Kish, J; Tapazoglou, E | 1 |
| Cascino, TL; Dinapoli, RP; Eagan, RT; O'Fallon, JR; O'Neill, BP; Scheithauer, B | 1 |
| Allen, JC; Bloom, J; Ertel, I; Evans, A; Hammond, D; Jenkin, D; Jones, H; Levin, V; Sposto, R; Wara, W | 1 |
| Al-Sarraf, M; Ensley, J; Kish, JA | 1 |
| Blessing, JA; Malfetano, J; Slayton, RE; Stehman, FB | 1 |
1 review(s) available for diaziquone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Glioma; Humans; Medulloblastoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds | 1986 |
5 trial(s) available for diaziquone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Drug Evaluation; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1991 |
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Drugs, Investigational; Humans; Neoplasm Recurrence, Local; Neoplasms | 1990 |
A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow Diseases; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Lymphoma; Neoplasm Recurrence, Local; Neoplasms | 1990 |
A phase II clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
Topics: Aged; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Uterine Neoplasms | 1988 |
Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Glioma; Humans; Medulloblastoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Nitrosourea Compounds | 1986 |
14 other study(ies) available for diaziquone and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence.
Topics: Aged; Antineoplastic Agents; Aziridines; Benzoquinones; beta-Galactosidase; Biomarkers; Cellular Senescence; Epithelial Cells; Formaldehyde; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paraffin Embedding; Primary Cell Culture; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Signal Transduction; Survival Analysis; Tissue Fixation | 2015 |
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Drug Evaluation; Glioblastoma; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local | 1984 |
Treatment of relapsed and refractory acute myeloid leukemia with diaziquone and mitoxantrone: a CALGB phase I study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis; Time Factors | 1990 |
Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Aziridines; Benzoquinones; Brain Neoplasms; Cohort Studies; Drug Therapy, Combination; Glioma; Humans; Lomustine; Male; Neoplasm Recurrence, Local; Procarbazine; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Intravenous BCNU and AZQ in patients with recurrent malignant gliomas.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Female; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local | 1989 |
Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma | 1985 |
Phase I-II evaluation of intra-arterial diaziquone for recurrent malignant astrocytomas.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow; Brain Neoplasms; Carmustine; Drug Evaluation; Eye; Female; Glioblastoma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neoplasm Recurrence, Local | 1986 |
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Aziridines; Benzoquinones; Carmustine; Cerebellar Neoplasms; Child; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Statistics as Topic | 1987 |
A phase I/II study of 24 hour intravenous AZQ in recurrent primary brain tumors.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Drug Evaluation; Humans; Infusions, Intravenous; Neoplasm Recurrence, Local | 1988 |
Response rate and toxicity with aziridinylbenzoquinone in patients with recurrent gliomas. A progress report.
Topics: Adolescent; Adult; Aged; Anemia; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia; Vomiting | 1988 |
Comprehensive phase II evaluation of aziridinylbenzoquinone (AZQ, diaziquone) in recurrent human primary brain tumors.
Topics: Adolescent; Adult; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Thrombocytopenia | 1987 |
Phase II evaluation of diaziquone in recurrent head and neck cancer.
Topics: Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Risk | 1986 |
Phase II clinical trial of diaziquone in the treatment of patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Aziridines; Azirines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1986 |
Effect of AZQ (1,4-cyclohexadiene-1,4-diacarbamic acid-2,5-bis(1-aziridinyl)-3,6 -dioxodiethylester) in recurring supratentorial malignant brain gliomas--a Phase II study. EORTC Brain Tumour Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Drug Evaluation; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1985 |